Dr Thomas Abbott, EFPIA co-lead for PIONEER, discusses data sources and access to data

Bookmark and Share
Published: 13 May 2019
Views: 510
Dr Thomas Abbott - Head, Real World Evidence at Astellas Pharmaceuticals

PIONEER is a European Network of Excellence for Big Data in Prostate Cancer, consisting of 32 partners, including ecancer, across 9 countries. Our goal is to ensure the optimal care for all European men living with prostate cancer by unlocking the potential of Big Data and Big Data analytics.

Dr Thomas Abbott describes his involvement with PIONEER as EPPIA co-lead and explains the type of data used within the platform and also the importance of real-world data.

For more information about the project, please visit the PIONEER website.

PIONEER is funded through the IMI2 Joint Undertaking and is listed under grant agreement No. 777492. This joint undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.